To determine whether CpG methylation prevents NR2F2-Iso2 expression, we treated two melanoma cell lines and two STCs with the DNA demethylating agent 5-aza-2′-deoxycytidine for 72 h. The gene discussed is NR2F2; the disease is melanoma.